Impact of COVID-19 on patients with congenital heart disease.

Cleary, Aoife; Chivers, Sian; Daubeney, Piers E; Simpson, John M

Cleary, Aoife; Chivers, Sian; Daubeney, Piers E; Simpson, John M.

Cleary A; Department of Paediatric Cardiology, Evelina London Children's Hospital, UK.
Chivers S; Department of Paediatric Cardiology, Royal Brompton Hospital, UK.
Daubeney PE; Department of Paediatric Cardiology, Royal Brompton Hospital, UK.
Simpson JM; National Heart and Lung Institute, Imperial College, London, UK.

Cardiol Young ; 31(1): 163-165, 2021 01.

Article in English | MEDLINE | ID: covidwho-1065757

Subject(s)

COVID-19/complications; Heart Defects, Congenital/complications; Adult; COVID-19/mortality; COVID-19/therapy; Cardiotonic Agents/therapeutic use; Child; Extracorporeal Membrane Oxygenation; Heart Defects, Congenital/therapy; Humans; Noninvasive Ventilation; Positive-Pressure Respiration; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Defects, Congenital Type of study: Experimental Studies / Prognostic study Topics: Long Covid Limits: Adult / Child / Humans Language: English Journal: Cardiol Young Journal subject: Vascular Diseases / Cardiology / Pediatrics Year: 2021 Document Type: Article Affiliation country: S1047951120004345

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google